Abstract
Background There is some debate in the literature as to whether fatigue persists in the long term in women who have completed adjuvant breast cancer treatment. Methods A systematic review was conducted in order to characterise and quantify the phenomenon of post treatment fatigue (PTF). Results There was a wide variation in the measures of fatigue used, duration of follow-up and type of comparison made. Overall 18 studies were identified with a follow-up period of between 4 months and 10 years. Fourteen studies demonstrated the presence of continued PTF and/or differences in fatigue levels compared to a reference population up to 5 years after treatment. One short-term study reported no increase in fatigue at 4 months. Three studies (with an average follow up period of longer than 5 years) did not identify overall quality of life differences in breast cancer survivors when compared with a reference population. However there were significant differences in measures of physical functioning and mental fatigue. Conclusion The authors conclude that there is good evidence of PTF occurring up to 5 years after completion of adjuvant therapy.
Similar content being viewed by others
References
Jacobsen P, Azzarello LM, Hann D et al (1998) Prevalence, predictors and course of fatigue during adjuvant chemotherapy for breast cancer. Psychosomatic Med 60:120–121
Berger AM (1998) Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Onc Nurs Forum 25(1):51–62
Shimozuma K, Ganz PA, Petersen L et al (1999) Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery. Breast Cancer Res Treatment 56(1):45–57
Jacobsen PB, Hann DM, Azzarello LM et al (1999) Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage 18(4):233–242
Geinitz H, Zimmermann FB, Stoll, P et al (2001) Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. Int J Radiation Oncol Biol Phys 51(3):691–698
Arnold BJ, Cumming CE, Lees AW et al (2001) Tamoxifen in breast cancer: symptom reporting. Breast Journal 7(2):97–100
Byar KL, Berger AM, Bakken SL et al (2006) Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncol Nursing Forum 33(1)
Bower JE, Ganz PA, Aziz N et al (2002) Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 64(4):604–611
Pinto BM, Maruyama NC (1999) Exercise in the rehabilitation of breast cancer survivors. Psycho-Oncology 8(3):191–206
Gielissen MF, Verhagen S, Witjes F et al (2006) Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial. J Clin Oncol 24(30):4482–4487
Helgeson VS, Tomich PL (2005) Surviving cancer: a comparison of 5-year disease-free breast cancer survivors with healthy women. Psycho-Oncology 14(4):307–317
Bergman B Aaronson, Ahmedzai NK et al (1994) The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC study group on quality of life. Eur J Cancer 30a(5):635–642
Ahn SH, Park BW, Noh DY et al (2007) Health-related quality of life in disease-free survivors of breast cancer with the general population. Ann Oncol 18(1):173–182
Andrykowski MA, Schmidt JE, Salsman JM et al (2005) Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol 23(27):6613–6622
Bower JE Ganz PA, Desmond KA et al (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18(4):743–753
Broeckel JA, Jacobsen PB, Horton et al (1998) Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 16(5):1689–1696
Curran SL, Beacham AO, Andrykowski MA (2004) Ecological momentary assessment of fatigue following breast cancer treatment. J Behav Med 27(5):425–444
de Jong N, Candel MJ, Schouten HC et al (2005) Course of mental fatigue and motivation in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol 16(3):372–382
Fan HG, Houede-Tchen N, Yi QL et al (2005) Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. Journal of Clinical Oncology 23(31):8025–8032
Hann DM, Jacobsen PB, Martin SC et al (1997) Fatigue in women treated with bone marrow transplantation for breast cancer: a comparison with women with no history of cancer. Supportive Care Cancer 5(1):44–52
Servaes P, Verhagen C, Bleijenberg G (2002) Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 38(1):27–43
Cella D, Davis K, Breitbart W, Curt G (2001) The fatigue coalition cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19(14):3385–3391
Smets EM, Garssen B, Bonke B et al (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39(3):315–325
Cella DF (1994) Manual: Functional Assessment of Cancer Therapy (FACT) Scales version 3. 1994, Chicago, Illinois: Rush-Presbyterian- St. Luke’s medical centre
Tchen N, Juffs HG, Downie F et al (2003) Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21(22):4175–4183
Jenkinson C, Coulter A, Wright L (1993) Short form 36 (SF 36) health survey questionnaire: normative data for adults of working age. Brit Med J 306:1437–1440
Hann DM, Jacobsen PB, Azzarello LM et al (1998) Measurement of fatigue in cancer patients: development and validation of the fatigue symptom inventory. Qual Life Res 7(4):301–310
McNair (1971) POMS McNair and Lorr EITS manual for the profile of mood states. Educational and testing service San Diego
Vercoulen J, Swanink CM, Fennis JF et al (1994) Dimensional assessment of chronic fatigue syndrome. J Psychosomatic Res 38:383–392
Bower JE, Ganz PA, Desmond KA et al (2006) Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer 106(4):751–758
Ganz PA, Desmond KA, Leedham B et al (2002) Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Nat Cancer Inst 94(1):39–49
Goldstein D, Bennett B, Friedlander et al (2006) Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC cancer 6(1):http://www.biomedcentral.com/1471–2407/6/240
Neyt M, Albrect J (2006) The long-term evolution of quality of life for disease-free breast cancer survivors: a comparative study in Belgium. J Psychosocial Oncol 24(3):89–123
Nieboer P, Buijs C, Rodenhuis S et al (2005) Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study [see comment]. J Clin Oncol 23(33):8296–8304
Robb C, Haley WE, Balducci L et al (2007) Impact of breast cancer survivorship on quality of life in older women. Crit Rev Oncol-Hematol 62(1):84–91
Servaes P, Gielissen MFM, Verhagen S et al (2007) The course of severe fatigue in disease-free breast cancer patients: a longitudinal study. Psycho-Oncology 16(9):787–785
Andrykowski MA, Curran SL, Lightner R (1998) Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med 21(1):1–18
Piper B, Lindsey AM, Dodd MJ et al (1989) The development of an instrument to measure the subjective dimension of fatigue. In: Funk S (ed) Key aspects of comfort: management of pain, Fatigue and Nausea. Springer, New York, p 199–208
Ganz P, Rowland JH, Meyerowitz BE (1998) Life after breast cancer: understanding women’s health-related qulaity of life and sexual functioning. J Clin Oncol 16:501–514
Hickie IB, Davenport TA, Hadzi-Pavlovic D et al (2001) Development of a simple screening tool for common mental disorders in general practice. Med J Aust 175(Supplement):s10–s17
Von Korff M, Ustun TB, Ormel J et al (1996) Self-report disability in an international primary care study of psychological illness. J Clin Epidemiol 49:297–303
Talbott EO, Norman SA, Baffone KM et al (1993) Selection of neighborhood controls for a study of factors related to the diagnosis of cervical cancer. J Clin Epidemiol 46:1277–1287
Helgeson VS, Cohen S, Schulz R, Yasko J (1999) J Education and Peer Discussion Group Interventions and Adjustment to Breast Cancer. Arch General Psychiatry 56(4):340–347
Stein KD, Jacobsen PB, Blanchard CM, Thors C (2004) Further validation of the multidimensional fatigue symptom inventory-short form. J Pain Symptom Manage 27(1):14–23
David A, Pelosi A, McDonald, E et al (1990) Tired, weak, or in need of rest: fatigue among general practice attenders. Br Med J 301(6762):1199–1202
CRUK (2007) Breast Cancer survival statistics 2007 [cited 2007 28.2.07]; Available from: http://www.info.cancerresearchuk.org/cancerstats/types/breast/survival/
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Minton, O., Stone, P. How common is fatigue in disease-free breast cancer survivors? A systematic review of the literature. Breast Cancer Res Treat 112, 5–13 (2008). https://doi.org/10.1007/s10549-007-9831-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-007-9831-1